Musculoskeletal System
Soral
Tenoxicam 20 mg / 2ml - 20 Capsules
Tenoxicam 20 mg - For IM and IV Injection
Composition:
Each Soral capsule contains 20 mg tenoxicam
Each Soral suppository contains 20 mg tenoxicam
Each Soral lyophilized vial contains 20 mg tenoxicam.
Therapeutic Indications:
Soral is indicated for the Long-term symptomatic treatment of pain and inflammation in osteoarthritis and
rheumatoid arthritis.
It is also indicated for the short-term management of acute musculoskeletal disorders including strains, sprains and other soft-tissue injunes
Approved by Egyptian Drug Authority: HF0294OA4548/102025 . Invalidation date: 20/10/2026
Kindly report any violated online promotional, educational and awareness material not having this message to The General administration for Regulation of Marketing & Advertising Materials at www.edaegypt.gov.eg”